Indira Gandhi Medical College   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Shimla India (1966)

Organization Overview

First Clinical Trial
2008
NCT00694915
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Dr. Rajendra Prasad Government Medical College; Indira Gandhi Medical College

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Transitional Cell (Phase 2)

Fatigue (Phase 3)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Sleepiness (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9